Record 275 patients in backlog, includes 180 authorizations and orders in Q1, up 48% over the prior year
Record 493 MyoPro candidates added to the pipeline in Q1
Revenue of $3.8 million, up 9% over the prior year
Conference call begins at 4:30 p.m. Eastern time today
BOSTON (May 8, 2024) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months ended March 31, 2024. Read more